Non-rodent models of diabetes are needed for practical and physiological reasons. Induction of mild insulin deficient diabetes was investigated in male Göttingen minipigs using streptozotocin (STZ) alone (75,100 and 125mg/kg) or 125mg/kg in combination with pretreatment with nicotinamide (NIA) (0, 20, 67,100,150 
Introduction
The study of the pathophysiology and treatment of diabetes requires well-characterized animal models that resemble aspects of the disease humans. Various forms of diabetes occur spontaneously or can be induced in several species of animals. Most of the available models are based on rodents, however non-rodent models of diabetes are urgently needed as a valuable supplement to rodents for both practical and physiological reasons.
The pig is useful as a model for human physiology and pathophysiology since many organ systems resemble those of the human. Of special interest for the study of diabetes is the similarities to humans found in the clinical chemistry (7, 10, 12, 14, 24, 26, 55) , nutrition and gastrointestinal tract (4, 8, 11, 20, 35, 40, 51) , pancreas development and morphology (21, 36, 37, 44, 49, 54) as well as metabolism (3, 35) .
These characteristics make swine an interesting species for studies of metabolic abnormalities in diabetes. The Göttingen minipig is especially suitable for long-term studies because of its small size and ease of handling, even at full maturity (6) .
Pancreatectomy has been investigated as a method of inducing diabetes in pigs (33, 34, 50, 55) . However high rates of mortality have been observed post operatively (50, 55) , meaning that this technique should be used with great caution and alternatives should be considered because of welfare considerations. Chemical induction of diabetes offers the advantage of preservation of both exocrine and endocrine cell populations other than β-cells, thus 4 resembling the situation in human diabetes (55) . Several stable models have been established for overt type 1 diabetes in the pig by the use of pharmacological induction of β cell damage with streptozotocin (STZ), either as single or repeated injections (2, 15, 16, 27, 28, 29, 46, 55) . Substantially increased fasting plasma glucose (FPG) leve ls and decreased insulin secretion in response to glucose stimuli have been obtained, as well as increases in plasma triglycerides and total cholesterol (27, 29) . Late complications typical of diabetes such as capillary basement membrane thickening and cataracts have also been shown in diabetic minipigs (28, 41) .
In other studies, alloxan has been used for induction of diabetes in pigs (11, 25, 41) . This compound, which has similar β-cell toxic properties as STZ, in a dose of 200 mg/kg in Yucatan minipigs induced severe diabetes with high mortality due to hypoglycemia following acute hyperinsulinaemia as a consequence of massive β-cell damage (41) . Doses of 80 mg/kg have been reported to induce mild diabetes with moderate hyperglycemia and partial loss of β-cell mass, with impaired insulin secretion rates, but normal fasting insulin levels in Göttingen minipigs (25) . Due to greater selectivity towards β-cells, wider range between doses causing mild and severe changes in glucose tolerance compared to alloxan (22, 23) , and the more extensive background literature on the effect of STZ in pigs, this compound was chosen for reduction of β-cell mass in the present study.
Despite of the widespread use of STZ, its use results in a wide variability in the extent of diabetes depending on species, strain, age and laboratory, thus limiting the predictability of its effects. Furthermore the efficacy of STZ varies even in an apparently uniform group of animals receiving the same dose of the compound (13, 47) .
In the present study, it was, therefore, investigated whether the use of nicotinamide (NIA) would have protective effects against the diabetogenic action of STZ in the Göttingen minipig 5 5 as previously reported in rats (31) . The protective effect of NIA against the effect of STZ has been shown in vivo to be both dose and pre-treatment time dependent, but even the most effective protective dose of NIA did not completely prevent the diabetogenic effects of STZ (23, 30) . Thus, a combination of these two compounds might be useful in the establishment of a non-rodent model of mild insulin deficient diabetes and in the present study, the doseresponse relations on glucose metabolism using two different approaches of pharmacological induction of abnormalities in the glucose tolerance are investigated in adult male Göttingen minipigs. The first approach was administration of a dose range of STZ (75, 100 and 125 mg/kg) alone, the second being administration of different doses of NIA (0-230 mg/kg) as a pre-treatment, in combination with STZ as a fixed high dose (125 mg/mg). The aim of the study was to obtain a reliable method of induction of impaired glucose tolerance and/or mild insulin deficient diabetes in the adult Göttingen minipig, characterized by reduced β-cell mass and disturbed residual insulin secretion leading to a decreased ability to dispose of glucose and a following, modest, hyperglycemia during oral glucose tolerance test (OGTT).
Materials and methods

Animals
Adult male Göttingen minipigs 11-14 months of age were obtained from the barrier unit at Ellegaard Göttingen minipigs ApS, Dalmose, Denmark. Animals were housed in single pens under controlled conditions (temperature was kept between 18 and 22 °C, relative air humidity was 30-70 % with 4 air changes per hour) with a 12h light: 12 h dark cycle and fed twice daily: 140 g of SDS minipig diet (SDS, Essex, England) and 240 g of a commercial swine fodder ("Svinefoder 22", Slangerup, Denmark) and allowed free access to water. The 6 pigs were studied at least two weeks post surgery and were trained carefully in all experimental procedures before start of experiments.
For the dosing studies with STZ alone, 14 animals were used weighing 18 ± 3 kg (range [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . For the dosing studies using NIA and STZ in combination, 38 animals were used weighing 22.5 ± 3.25 kg (range 16.9 to 28.9). These animals served as their own control and were studied both before and after induction of diabetes.
Principles of laboratory animal care were followed and the type of study was approved by the Animal Experiments Inspectorate, Ministry of Justice, Denmark. the following 2 days. All animals were allowed 2-3 weeks of recovery after the surgical procedure and had normal behavior and eating patterns at the start of the study period.
Surgical implantation of central venous catheters
Protocol 1: Mixed Meal Oral glucose tolerance test
The Mixed Meal Oral Glucose Tolerance Test (OGTT) was performed in all animals in the NIA and STZ combination study one week before and one week after exposure to NIA and STZ. The test was performed in non-restrained, freely moving animals in their usual pens to reduce the amount of stress experienced by the animals during testing.
After an 18-hour overnight fast, animals were offered a mixed meal oral glucose tolerance test of 25 g SDS minipigfodder and 2g/kg glucose (500 g/l, SAD, Copenhagen, Denmark). The meal was eaten, rapidly and without stress, from a bowl under supervision.
Blood samples were obtained from the jugular vein catheters at t = -15, -5, 0, 15, 30, 45, 60, 90, 120, 150, and 180 minutes relative to the fodder and glucose load.
Protocol 2: Intravenous glucose and arginine challenge
This test was performed two weeks (16±2 days) (n=6) or two months (60±0 days) (n=2) after dosing of NIA+STZ in the NIA 67 mg/kg group and a control group of normal, age matched, animals (n=14) to evaluate insulin secretory capacity. The test was performed in nonrestrained, freely moving animals to reduce the amount of stress experienced by the animals during testing.
After an 18-hour overnight fast, animals were dosed with an intravenous bolus of glucose 
Protocol 3: Examination of STZ dosed animals
The examination of animals dosed with STZ alone was limited to measurement of fasting plasma values of glucose, insulin and glucagon.
Handling and analysis of blood samples
Blood samples (2 ml of whole blood) were immediately transferred to vials containing EDTA (1.6 mg/ml final concentration) and aprotinin 500 KIU/ ml full blood (Trasylol ® , 10.000 KIU/ml, Bayer, Lyngby, Denmark) and were kept on ice until centrifugation. Samples were centrifuged (4°C, 10 min, 3500 rpm) and plasma separated and stored at -20°C until analysis.
Plasma glucose was analyzed using the immobilized glucose oxidase method, 10 µl of plasma in 0.5 ml buffer (EBIO plus autoanalyzer and solution, Eppendorf, Hamburg, Germany).
Plasma insulin was analyzed in a two-site immunometric assay with monoclonal antibodies as catching and detecting antibodies (Catching antibody HUI-018 raised against the A-chain of human ins ulin. Detecting antibody OXI-005 raised against the B-chain of bovine insulin) (1) and using purified porcine insulin for calibration of the assay. The minimal detectable concentration was 3.2 pM, the upper limit was 1200 pM (no sample dilution) and the interand intra-assay variations at three concentration levels were 15.3% and 3.2% (at 342 pM), 9 9.9% and 7.6% (at 235 pM) and 14.6% and 4.4% (at 87 pM). Recovery at high, medium and low concentration levels was 97.1%, 97.9% and 101% respectively. A commercial kit from Linco was used to measure glucagon concentrations (Glucagon RIA kit, Cat.# GL-32K).
Performance data for the glucagon assay as given by the supplier were: CV of 10.3% (39 pg/ml, ED80), 7.7% (104 pg/ml, ED50) and 7.8% (271 pg/ml, ED20). Vomiting was seen in all animals during the first hours after administration of STZ, and this seemed to be unaffected by NIA pretreatment. Most animals were eating and behaving normally 24 to 48 hours after dosing. Animals were offered SDS fodder 2 hours after administration of NIA and STZ and were observed frequently during the first 2 days after administration of NIA and STZ. Blood glucose was monitored regularly to avoid episodes of hypoglycemia due to sudden hyperinsulinemia caused by necrosis of β-cells. 
Induction of diabetes
Histological examination of pancreas
Fixation and physical fractionation
Histological examination was performed one month (27±8 days) (n=7) or two months (60±0 days) (n=4) after dosing of NIA (67mg/kg) and STZ and compared with data from normal animals (n=5). Furthermore, an animal that received STZ alone was included for comparison.
At the end of the study period, after euthanasia with pentobarbitone ( 
Immunohistochemistry
Sections were deparaffinised in xylen, brought to 99% ethanol, treated with 0.5%H 2 O 2 for 20 min to block endogenous peroxidase activity, and rinsed with Tris-buffered saline (TBS).
Sections were then immersed in 0.01M citrate buffer pH 6, preheated to 90°C and submitted to antigen retrieval by microwave oven treatment for 3x5min heating at 80% (Polar Patent, Umeå, Sweden). The slides were subsequently cooled, still in the citrate buffer, by immersion of the jar in running tap water, rinsed in TBS + 0.01%Triton X-100 (Sigma, St. Louis, MO, USA) (TBS-T buffer), and the tissue sections 'ringed' with a DAKO-pen (DAKO, Copenhagen, Denmark).
Insulin staining
The following stainingsteps were carried out in an Autostainer (DAKO, Copenhagen , 
Non-β cell staining
These staining steps were also carried out in an Autostainer (DAKO, Copenhagen, Denmark).
All dilutions were carried out with TBS + 0.01% Triton X-100 (TBS-T). Sections were 
Stereological estimation of β-and non-β-cell mass
β and non-β endocrine cell mass was evaluated stereologically in 2-3 sections 250 µm apart in an Olympus BX-50 microscope (Olympus, Denmark, Copenhagen) with video camera and monitor at a total on-screen magnification of 960x. The sections were analysed by point counting of frames after systematic uniform random sampling using a PC-controlled motorized stage and the CAST-GRID software (Olympus, Denmark, Copenhagen).
Initially, the tissue sections were circumscribed using a 1.25x objective and within this area the counting of endocrine and exocrine structures took place. The volume fractions of beta or non-beta cells were estimated by point counting stereological techniques (18) at a total onscreen magnification of 960x obtained with a 20x objective, a grid of 4x64 points, and step lengths of max 900x600 µm controlled by the CAST-GRID software. The sections were examined with the origin of the sections blinded to the observer. Mean values of estimated volume fractions were calculated with correction for the differences in total areas counted.
Statistics
Calculations of fasting values and AUC (baseline=0 for glucose and insulin during OGTT (protocol 1), baseline subtracted for glucagon during OGTT (protocol 1) and for insulin during glucose and arginine stimulation test (protocol 2)) and statistical evaluation of results was performed using paired two tailed Students t-test, Kruskal-Wallis test and linear regression using Excel (2000) and GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, CA, USA). Comparison of slopes of regression lines was performed using the method described by Zar (56) . p-values of 0.05 or less were considered significant.
Results
Normal plasma profiles during OGTT (protocol 1)
Based 
Plasma profiles during OGTT (protocol 1) after administration of NIA and STZ
A significant increase in FPG was found in the NIA 100, 67, 20 and 0 groups but not in the NIA 230 and 150 mg/kg groups (table 2), the correlation being significant between log dose of NIA and FPG (r 2 = 0.4339, p<0.001) ( fig.1) . A significant decrease in FPI was found in the NIA 67 mg/kg group, but this most probably is due to high values of FPI before NIA+ STZ in this group, since changes in all other groups were non-significant. There was no significant correlation between log dose of NIA and FPI (r 2 = 0.0052, p=0.687).
No significant changes in FPGa were detected in any of the dosing groups.
A significant increase in AUC glucose was found in all dosing groups except the NIA 230 mg/kg group (table 3) . Changes in glucose levels are illustrated in fig.2 and there was a significant correlation between the log NIA dose and AUC glucose (r 2 = 0.2970, p<0.001) (data not shown).
Furthermore, there was a significant correlation between AUC glucose and FPG (r 2 =0.880, p<0.0001) ( fig.3) . A significant decrease in AUC insulin was found in the NIA 150, 67 and 0 mg/kg groups. In the other groups, a non-significant trend for lowering of AUC insulin was seen.
When AUC insulin after NIA20 mg/kg and STZ were compared to the AUC insulin (pM·min) from the 38 normal OGTT profiles, there was a significant decrease (from 42087 ± 21637 to 7970 ± 2702, p=0.03). There was no significant correlation between log NIA dose and AUC insulin (r 2 = 0.00875, p= 0.599). No significant changes in AUC glucagon were found in any of the groups.
Significant increases in 2h-PG were found in the NIA 100, 20 and 0 mg/kg groups and nonsignificant increases were seen in the NIA 150 and 67 mg/kg groups. A non-significant decrease was seen in the NIA 230 mg/kg group and there was a significant correlation between log NIA dose and 2-hPG (r 2 = 0.2989, p<0.001) (data not shown).
Duration of reduction of β -cell function and mass
Over the period in which the intravenous glucose and arginine challenge (protocol 2) was performed, FPG (mM) was consistently elevated in the NIA+STZ dosed animals (4. 
Discussion
Attempts to genetically select a strain of diabetic pigs have been made (38, 39, 40) but have, so far, not been confirmed to be successful (19) . The use of pancreatectomized animals as a model of diabetes (15, 33, 34, 50) has the disadvantage of also removing the exocrine function of the pancreas and the non-beta-cell endocrine cells of the islets of Langerhans and, although, performance of partial pancreatectomy might be useful for induction of mild diabetes, this method clearly is more invasive compared to the administration of STZ.
Pigs are more resistant to the diabetogenic effects of STZ than rats (2, 13, 15, 16, 23, 27, 28, 29, 31, 46, 55) and non human primates (42) , and a wide individual variability in the response to STZ was seen in the present study as has also been shown in non human primates (42) . In the present study, only male animals were included to reduce variability in glucose tolerance due to estrous cycling and probably the diversity of genetic background is the best explanation for the wide variability seen, as diet and nutritional status were standardized in the present experiment.
Previous observations showing that 35-40 mg/kg STZ did not influence glucose metabolism in pigs (15, 29) are consistent with data from the present study. In the present study all animals in the STZ 100 mg/kg group and 5 out of 7 animals in the STZ 125 mg/kg group were classified as severely diabetic, whereas the remaining 2 animals from the STZ 125 mg/kg group had impaired fasting glucose (IFG). Thus, these data demonstrate that adult male Göttingen minipigs can be made severely diabetic using a dose of STZ of 100-125 mg/kg or above. This is in accordance with previous observations in minipigs and domestic pigs, with 100-150 mg/kg STZ inducing overt diabetes (9, 15, 16, 55) . The response to 100 or 125 mg/kg STZ showed some individual variation, indicating individual grades of sensitivity to STZ alone, in accordance with previous observations (13, 47) . The effects of STZ alone, expressed as increased FPG and decreased FPI and FPC, are significantly correlated to log dose of STZ, and show a clear dose response relationship and despite the individual variation, this dosing regimen seems to be a reliable method for pharmacological induction of overt diabetes. However, based on the present results, the dosing window in which induction of mild, insulin deficient diabetes can be accomplished seems very narrow due to the steepness of the dose-response curve to STZ alone.
The present results show that NIA is indeed capable of partially protecting β-cells from the damaging effects of STZ in the Göttingen minipig as has also been shown previously in rats (23, 30, 31) .
The use of NIA seems feasible for induction of mild type 1/insulin deficient diabetes, since the changes in FPG in response to changing doses of NIA are significantly smaller compared to changing doses of STZ. This can be seen when comparing the regression lines for log dose NIA or STZ and FPG ( fig.2) , with the regression line based on changing STZ dose having a much steeper slope (30 ± 7) compared to that for the changing NIA dose (-7 ± 2) (p<0.001).
NIA in a dose of 67 mg/kg in combination with STZ seems to be useful regimen for induction of mild insulin deficient diabetes.
However, the protective effect of NIA is not complete, as even the highest dose of NIA could not fully prevent the effect on the β-cells, as has also been shown in rats (23, 30) .
The ratio of insulin to glucose at 30 minutes during the OGTT was decreased even in the animals that had normal glucose tolerance (NGT) post NIA+STZ compared to pre NIA+STZ values (25.8±11.5 vs. 61.2±28.0, p<0.001). Furthermore there was a gradual decrease in the ratio post NIA+STZ from the NGT animals through the glucose intolerant animals (17.7±11.1) and mildly diabetic animals (9.2 ± 8.8) to the overtly diabetic animals (2.6 ± 3.2) (p<0.001) ( fig.6 ), which is similar to what has been observed in humans (53) . The fact that this ratio is also decreased in the animals with normal glucose tolerance after dosing with NIA+STZ compared to pre NIA+STZ values indicates some deterioration of insulin secretory response to glucose even in these animals.
The protection by NIA seems to be negligible when doses of 20 mg/kg or below are used. In the dosing range 150-67 mg/kg of NIA, mild diabetes could be induced even though some variability existed within the dosing groups, with the diabetic animals having moderately increased fasting plasma glucose and higher residual insulin secretory capacity compared to diabetic animals from the NIA 20 and 0 mg/kg groups.
Administration of NIA and STZ in combination has been known to induce insulin producing tumors in the pancreas of rats (45) . In the present study, no tumors were found during histological examination of pancreatic tissues from animals for up to two months after dosing of NIA + STZ. Diabetes induced by STZ has previously been shown to be stable in some experiments (9, 55) , while other studies have shown a gradual improvement of glucose tolerance (27) . In the present study, the ele vated FPG after NIA+STZ was stable in the seven tested animals for a period of two weeks to two months after dosing. Furthermore, there was a very significant reduction in insulin secretory response to both glucose and arginine after the same period of time. Finally, the in vivo measures of reduced insulin secretory capacity was confirmed histologically by reduced β-cell mass in the model. The stability of the IGT/diabetes in this model beyond two months after dosing has yet to be investigated in detail.
In conclusion, these studies have shown that varying degrees of glucose intolerance and diabetes can be induced in male Göttingen minipigs with STZ and that NIA has protective effects in β-cells in these animals as has also been shown in rats. There seems to be a rational 
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